TB-500 Cost: What You'll Actually Pay in 2026

Executive Summary

TB-500 pricing looks simple from the outside — search the query and you will find research-vendor vials for $30 to $100. But that number is almost never the real cost of TB-500, because it excludes everything that determines whether you are getting something useful or just an unlabeled compound with no care behind it. A complete cost picture for TB-500 in 2026 has to account for the care path: who evaluated you, who sourced the compound, who is monitoring your response, and who you call if something goes wrong.

The February 2026 FDA peptide reclassification has also changed the pricing landscape. A subset of peptides were moved back into Category 1 (approvable for compounding pharmacies), which means the supply and cost picture for clinic-dispensed peptides is in flux. TB-500's category status specifically affects what a 503A or 503B pharmacy can supply and at what price — and that in turn affects what a legitimate clinic program costs versus what a research vendor is actually providing. The price gap between the two paths is still large, and this guide breaks down exactly why.

For the companion pricing guide on the other half of the Wolverine stack, see BPC-157 cost guide 2026. For the full evidence and safety picture behind both compounds, see BPC-157 and TB-500: what the research actually shows. For broader peptide clinic evaluation criteria, see best peptide clinics online 2026.

At-a-Glance Comparison

TB-500 cost by access path in 2026. Research-vendor pricing excludes consultation, monitoring, sourcing accountability, or lab-based safety checks. Clinic pricing includes clinical oversight but varies significantly by program structure. All figures are approximate 2026 market rates. The Feb 2026 FDA reclassification is shifting compounding-pharmacy supply for some peptides; costs may change through H1 2026.

Why TB-500 pricing is harder to compare than it looks

The apparent simplicity of TB-500 pricing — a research vial in the $30–$100 range — obscures how much the care path determines whether you are getting a usable product or just a cost transfer with no clinical value. Buyers searching for tb-500 cost usually start with a price question, but the stronger decision model is to evaluate clinical process quality, medication reliability, and support accountability at the same time. In telehealth programs, those three variables determine whether your first protocol can be sustained or has to be rebuilt after 60 to 90 days.

TB-500 is the synthetic fragment that maps onto thymosin beta-4 signaling. It is commonly marketed for recovery, cell migration support, soft-tissue flexibility, and broader injury-healing narratives. Most of the pricing people encounter in quick searches comes from research-peptide vendors — and that pricing is intentionally low because it excludes everything else: no evaluation, no sourcing verification, no monitoring cadence, and no accountability chain if you have an adverse event. What a legitimate clinic program costs is different because it includes physician or NP review, a named 503A or 503B compounding pharmacy source, injection technique support, and follow-up care. The price gap between those two paths can be $200–$600 per month, and it almost entirely reflects what is or is not included in the fee. Before you compare any two TB-500 prices, you need to know which path each number belongs to. Comparing research-vendor per-vial cost against clinic monthly program cost is not a like-for-like comparison — it is comparing a raw compound against a supervised care episode. For the equivalent BPC-157 cost breakdown, see BPC-157 cost guide 2026. A practical way to lower decision regret is to document baseline labs, symptom goals, budget limits, and acceptable side-effect tolerance before enrollment. This turns provider conversations into comparable data points instead of marketing impressions. It also makes follow-up optimization faster because your care team can anchor every change to objective measurements and timeline milestones.

Common failure mode: buyers anchor on the lowest number they see in search results and try to negotiate toward it, even when the lowest number reflects the path with the fewest safeguards and the least clinical value. Avoid that by using explicit check-ins at week 4, week 8, and week 12. If outcomes are under target and side effects are rising, escalate quickly or switch provider pathways instead of waiting for momentum to "self-correct."

What research-vendor TB-500 actually costs — and what you do not get

The research-peptide lane is where most buyers start because it is the cheapest entry point. Understanding exactly what that pricing includes and excludes is how you decide whether the savings are real or illusory. Buyers searching for tb-500 cost usually start with a price question, but the stronger decision model is to evaluate clinical process quality, medication reliability, and support accountability at the same time. In telehealth programs, those three variables determine whether your first protocol can be sustained or has to be rebuilt after 60 to 90 days.

Research-peptide vendors typically sell TB-500 in 5mg or 10mg vials at prices ranging from $30 to $100 depending on vial size, vendor, and batch quality claims. Monthly protocol dosing is typically in the range of 5–10 mg per week during a loading phase and 2–5 mg per week during a maintenance phase, so a month of research-peptide sourcing might cost anywhere from $30 to $200 depending on dose and vendor. That looks dramatically cheaper than clinic care. But the exclusions are significant: no prior evaluation, no prescription, no pharmacy accountability, no sourcing verification, no sterility guarantee, no monitoring, and no accountability if something goes wrong. The FDA's Category 2 classification of BPC-157 specifically cited impurity concerns with compounding and research-peptide supply chains. TB-500's regulatory position is evolving as the Feb 2026 reclassification continues to play out — and that uncertainty affects research-vendor product quality even when vendor marketing is confident. There is also a practical risk: buyers in this lane typically manage bacteriostatic water reconstitution, injection technique, dosing math, and supply timing on their own — all of which introduce error points that clinical guidance eliminates. For the full sourcing-quality risk discussion, see peptide therapy side effects and safety. A practical way to lower decision regret is to document baseline labs, symptom goals, budget limits, and acceptable side-effect tolerance before enrollment. This turns provider conversations into comparable data points instead of marketing impressions. It also makes follow-up optimization faster because your care team can anchor every change to objective measurements and timeline milestones.

Common failure mode: buyers assume the compound from a research vendor is equivalent to what a clinic dispenses through a named pharmacy. In practice, purity, sterility, and potency can vary substantially across research-vendor batches, and there is no third-party accountability. Avoid that by using explicit check-ins at week 4, week 8, and week 12. If outcomes are under target and side effects are rising, escalate quickly or switch provider pathways instead of waiting for momentum to "self-correct."

What a clinic TB-500 program costs — and what you are actually paying for

Clinic-based peptide programs cost more than research vendors for a reason. Understanding the value breakdown helps you decide whether the premium is worth it for your specific situation. Buyers searching for tb-500 cost usually start with a price question, but the stronger decision model is to evaluate clinical process quality, medication reliability, and support accountability at the same time. In telehealth programs, those three variables determine whether your first protocol can be sustained or has to be rebuilt after 60 to 90 days.

Specialist peptide clinics — the tier that includes practices like Marek Health, Defy Medical, and comparable telehealth-plus-specialist models — typically structure TB-500 programs in the range of $175–$450 per month for the medication component, with initial consultation ($150–$400) and possible lab fees ($100–$250) added on top. That puts a realistic first-month all-in cost at $425 to $1,100 for a well-supervised entry program. What you are paying for beyond the compound: physician or NP review before prescribing, compounding pharmacy sourcing with a documented chain of custody, reconstitution and injection support, follow-up consultations when needed, and an escalation path if you have an adverse event. Convenience-first clinics (med-spas, wellness practices without a specialist focus) typically land in a middle tier: $120–$300 per month for medication, with lighter evaluation depth and more variable monitoring cadence. The distinction matters because the quality of what you get for that fee is highly clinic-specific. For the five-variable clinic evaluation framework, see best peptide clinics online 2026. A practical way to lower decision regret is to document baseline labs, symptom goals, budget limits, and acceptable side-effect tolerance before enrollment. This turns provider conversations into comparable data points instead of marketing impressions. It also makes follow-up optimization faster because your care team can anchor every change to objective measurements and timeline milestones.

Common failure mode: buyers assume that a higher price automatically means better care. In practice, some high-price med-spa programs offer weaker evaluation and monitoring than well-structured mid-price telehealth options. Price is a weak proxy for quality. Avoid that by using explicit check-ins at week 4, week 8, and week 12. If outcomes are under target and side effects are rising, escalate quickly or switch provider pathways instead of waiting for momentum to "self-correct."

Stack pricing: what the BPC-157 + TB-500 Wolverine stack actually costs

Many buyers come to TB-500 cost questions because they are already researching the BPC-157 + TB-500 stack. The stack cost picture is not simply additive — it depends on which path and which clinic structure you are using. Buyers searching for tb-500 cost usually start with a price question, but the stronger decision model is to evaluate clinical process quality, medication reliability, and support accountability at the same time. In telehealth programs, those three variables determine whether your first protocol can be sustained or has to be rebuilt after 60 to 90 days.

If you source both BPC-157 and TB-500 through research vendors, the stack cost looks cheap: $60–$200 per month total for both compounds, depending on vendor, vial sizes, and dosing schedule. That is the lowest-cost entry point, but it also combines two sources of sourcing uncertainty into a single protocol — which means more complexity and more potential for quality variation on both compounds simultaneously. In clinic-based care, the BPC-157 + TB-500 stack is typically priced as a package protocol: specialist clinics often run combined programs in the range of $300–$900 per month, depending on program depth, which compounds are included, monitoring frequency, and whether the consultation and labs are bundled. Some clinics price the stack as an add-on to a base TRT or peptide program, which can reduce the marginal cost if you are already paying for a monthly base fee. The key question is not just what the stack costs — it is whether the stack is actually the right protocol for your situation at all. Many buyers who come in asking about the BPC-157 + TB-500 stack leave with a single-pathway recommendation because their clinician explains that two simultaneous low-evidence compounds make outcomes harder to attribute and adjust. For the full evidence and decision framework behind the stack, see BPC-157 and TB-500: what the research actually shows. A practical way to lower decision regret is to document baseline labs, symptom goals, budget limits, and acceptable side-effect tolerance before enrollment. This turns provider conversations into comparable data points instead of marketing impressions. It also makes follow-up optimization faster because your care team can anchor every change to objective measurements and timeline milestones.

Common failure mode: buyers add the BPC-157 and TB-500 costs together and assume the stack is a natural choice. In practice, combining two low-evidence compounds doubles the complexity without doubling the evidence for the combination. Avoid that by using explicit check-ins at week 4, week 8, and week 12. If outcomes are under target and side effects are rising, escalate quickly or switch provider pathways instead of waiting for momentum to "self-correct."

Six-month TB-500 budget model: what a responsible course really costs

Buyers often focus on monthly pricing without modeling what a realistic course — from first consultation to protocol completion — actually costs. A six-month budget model makes the real commitment visible before you start. Buyers searching for tb-500 cost usually start with a price question, but the stronger decision model is to evaluate clinical process quality, medication reliability, and support accountability at the same time. In telehealth programs, those three variables determine whether your first protocol can be sustained or has to be rebuilt after 60 to 90 days.

A typical TB-500 protocol in a supervised setting runs 8–12 weeks for a loading phase (higher dose frequency) and 4–12 weeks of maintenance or taper. Many buyers who enter a TB-500 program stay for four to six months when including consultation, initial loading, and outcome assessment. Here is what a responsible six-month budget looks like across the three care paths:

Research-vendor path (six months): compound costs of $120–$600 depending on dose and protocol, plus $20–$60 in supplies = total $140–$660. No consultation, no monitoring, no accountability. Med-spa / convenience clinic (six months): $0–$150 initial consultation + $0–$150 labs + $720–$1,800 medication over six months + $0–$450 in follow-up visits = $720–$2,550 depending on program structure. Specialist clinic (six months): $150–$400 initial consultation + $100–$250 labs + $1,050–$2,700 medication over six months + $150–$600 in monitoring visits = $1,450–$3,950.

The wide ranges reflect genuine program variation in this market. The key insight is that the lowest realistic cost for supervised care over six months is still roughly 3–5× the lowest cost for research-vendor sourcing — and the premium reflects evaluation, pharmacy accountability, monitoring, and what happens when something goes wrong. For context on what a full peptide program budget looks like across multiple compounds, see peptide therapy cost guide. A practical way to lower decision regret is to document baseline labs, symptom goals, budget limits, and acceptable side-effect tolerance before enrollment. This turns provider conversations into comparable data points instead of marketing impressions. It also makes follow-up optimization faster because your care team can anchor every change to objective measurements and timeline milestones.

Common failure mode: buyers model one month of medication cost and assume that is the total commitment. The real cost of a supervised course is 4–6× the monthly fee when you include consultation, labs, supplies, and monitoring over a realistic protocol duration. Avoid that by using explicit check-ins at week 4, week 8, and week 12. If outcomes are under target and side effects are rising, escalate quickly or switch provider pathways instead of waiting for momentum to "self-correct."

Red flags in TB-500 pricing — and how to find clinics worth shortlisting

Not all TB-500 programs are equally priced and not all are equally legitimate. Recognizing the pricing patterns that signal weak clinical quality protects you from paying for access rather than care. Buyers searching for tb-500 cost usually start with a price question, but the stronger decision model is to evaluate clinical process quality, medication reliability, and support accountability at the same time. In telehealth programs, those three variables determine whether your first protocol can be sustained or has to be rebuilt after 60 to 90 days.

Several pricing patterns should raise flags regardless of how compelling the clinic's marketing looks. Vague pharmacy sourcing: if a clinic cannot name the compounding pharmacy filling your TB-500 prescriptions, you cannot verify their supply chain. Missing evaluation requirements: if a clinic will start you on TB-500 without any consultation or labs, they are running an access business, not a clinical practice. Unusually low monthly fees for 'full supervision': the median cost of real clinical oversight in 2026 is not $75 per month — if a clinic claims to offer supervised peptide programs at near-vendor pricing, ask very specifically what monitoring, follow-up, and escalation are included. Stack-first selling: clinics that lead with BPC-157 + TB-500 packages before understanding your situation are selling a product, not providing care. No outcome discussion: if a clinic cannot explain what success looks like, what timeline to expect, and what would cause them to modify or stop the protocol, you have no accountability anchor. For the full clinic evaluation framework, see best peptide clinics online 2026, and use our provider comparison tool to build your shortlist. A practical way to lower decision regret is to document baseline labs, symptom goals, budget limits, and acceptable side-effect tolerance before enrollment. This turns provider conversations into comparable data points instead of marketing impressions. It also makes follow-up optimization faster because your care team can anchor every change to objective measurements and timeline milestones.

Common failure mode: the TB-500 market in 2026 has enough legitimate options and enough low-quality operators that price alone is a weak quality signal in either direction. Cheap does not mean low-quality and expensive does not mean rigorous. Avoid that by using explicit check-ins at week 4, week 8, and week 12. If outcomes are under target and side effects are rising, escalate quickly or switch provider pathways instead of waiting for momentum to "self-correct."

Internal Resources to Compare Next

Use these pages to validate assumptions before spending. Cross-checking provider model details with treatment-specific pages is the fastest way to reduce preventable cost drift in month two and month three.

Compare Providers Before You Purchase

If TB-500 is on your shortlist, compare clinics on sourcing accountability, evaluation depth, and monitoring structure — not just monthly medication price. Use our provider comparison tool to find peptide-friendly practices that can tell you whether TB-500 alone, the BPC-157 stack, or neither is the right call for your specific situation.

Disclosure: PeakedLabs may earn a commission from partner links. Editorial scoring and rankings remain independent.

Frequently Asked Questions

How much does TB-500 cost per month in 2026?

TB-500 costs vary significantly by care path. Research-vendor peptides typically run $30–$100 per 5mg vial with no clinical oversight. Convenience clinic programs run $120–$300 per month for the medication component. Specialist clinic programs (Marek Health, Defy Medical equivalents) run $175–$450 per month for medication, with consultation and lab fees on top. The total first-month cost for a full specialist program is typically $425–$1,100.

Why is there such a big price difference between research vendors and clinics?

The price gap is almost entirely explained by what is included. Research-vendor pricing covers only the compound — no evaluation, no pharmacy accountability, no monitoring, and no escalation path. Clinic pricing covers the compound plus consultation, named pharmacy sourcing, injection guidance, monitoring follow-up, and an accountable care structure. These are not equivalent products; one is a compound and the other is a care episode.

How much does the BPC-157 and TB-500 stack cost?

Research-vendor stack sourcing typically runs $60–$200 per month for both compounds combined, with no clinical oversight. Specialist clinic stack programs typically run $300–$900 per month depending on program structure, which compounds are included, and monitoring depth. Many buyers find that the stack is not necessary for their situation and that a single-compound protocol reduces cost and improves protocol clarity.

Is it worth paying clinic prices for TB-500?

That depends on your medical history, risk tolerance, and what you need the protocol to accomplish. For buyers with complex health backgrounds, active medications, or any history of immune or clotting conditions, clinic-based care is significantly safer than self-sourcing. For buyers who are otherwise healthy, understand the evidence limitations, and accept the sourcing risk, research-vendor access is cheaper — but not risk-free.

What is included in a typical TB-500 clinic program fee?

It varies significantly. A well-structured specialist program should include: physician or NP review before prescribing, compounding pharmacy sourcing with a documented chain of custody, injection technique guidance, a monitoring schedule, and an escalation path for side effects. Low-quality programs may include only medication with a nominal check-in. Always ask what the fee covers before committing.

How much bacteriostatic water and supplies do I need for TB-500?

If you are in the research-peptide lane, you will typically need bacteriostatic water (usually 10mL per vial reconstitution), 1mL insulin syringes, alcohol swabs, and a sharps disposal container. Budget $15–$40 for a full supply kit. Clinic programs typically include or provide these through their pharmacy, which removes this coordination burden from the buyer.

Does the 2026 FDA peptide reclassification change TB-500 pricing?

The February 2026 reclassification moved some peptides back into Category 1 (approvable for 503A/503B compounding pharmacies), which should stabilize or reduce compounding pharmacy pricing for those compounds through H1 2026. TB-500's specific regulatory status continues to evolve. Research-vendor pricing is not directly affected by FDA compounding categories, but the reclassification does affect supply chain accountability at the clinic level.

Can I get TB-500 cheaper if I am already on a TRT program?

Often yes. Many TRT clinics and specialist practices offer bundle pricing when adding peptide protocols to an existing program. If you are already paying a monthly fee for TRT care, ask explicitly what it costs to add TB-500 as an adjunct. The marginal fee is often lower than starting a standalone peptide program from scratch.

What is a realistic six-month cost for a supervised TB-500 program?

At a specialist clinic, a six-month all-in estimate typically runs $1,450–$3,950 including initial consultation, baseline labs, medication over six months, and monitoring visits. At a convenience clinic, expect $720–$2,550. Research-vendor sourcing over six months typically runs $140–$660 for the compound plus supplies, with no clinical safety net included.

What should I look for in a TB-500 clinic to make sure I am not overpaying for poor care?

Ask five questions: Which compounding pharmacy fills your TB-500? What does the monthly fee actually include? What is the monitoring schedule? What happens if I have a side effect? And what would cause you to modify or stop my protocol? If any of those answers are vague, the clinic is probably not worth the premium. Use our provider comparison tool to shortlist options that meet a higher accountability standard.